Difference between revisions of "Team:UCopenhagen/HP/Ethics"

 
Line 6: Line 6:
  
 
<!-- Header -->
 
<!-- Header -->
     <a name="project-page"></a>
+
     <a name="landsholdet"></a>
 
     <div class="intro-header4">
 
     <div class="intro-header4">
 
         <div class="container">
 
         <div class="container">
Line 14: Line 14:
 
                     <div class="intro-message2">
 
                     <div class="intro-message2">
 
<h3></h3>
 
<h3></h3>
<h3></h3>
+
                         <h1> E T H I C S</h1>
<h3></h3>
+
<h3></h3>
+
<h3></h3>
+
                         <h1>E T H I C S </h1>
+
                        <h3></h3>
+
           
+
 
                     </div>
 
                     </div>
 
                 </div>
 
                 </div>
Line 27: Line 21:
 
         </div>
 
         </div>
 
         <!-- /.container -->
 
         <!-- /.container -->
 
    </div>
 
    <!-- /.intro-header -->
 
 
  
 
<div class="content-section-a">
 
<div class="content-section-a">
 
<div class="container">
 
<div class="container">
             <div class="row">
+
             <div>
                <div class="col-lg-5 col-sm-6">
+
                    <hr class="section-heading-spacer">
+
 
                     <div class="clearfix"></div>
 
                     <div class="clearfix"></div>
                     <h2 class="section-heading">Introduction </h2>
+
                     <h2 class="section-heading"> </h2>
                     <p class="lead">Our team believes that establishing a stable platform for scientists to create naïve orthogonal living compartments, would allow for an unpredictable advancement in the field of synthetic biology. Our project will not attempt to create an endosymbiont, but instead investigate the mechanisms in free-living cells in a bottom-up approach to endosymbiosis.   
+
                     <p class="lead">
The endosymbiotic theory, formulated in the early years of the previous century, outlines that the organelles of the eukaryotic cell, such as the mitochondria, have their origin in free-living prokaryotes engulfed by bigger cells. These incorporated cells then co-evolved with their host conferring to it novel emergent properties which ultimately helped fuel the development of more complex multicellular biological systems such as plants and animals (Archibald, 2015). </p>
+
Similar to most iGEM projects Incell as a scientific project heavily relies on our’s and the scientific community’s ability to genetically modify organisms. In other words, we are
 
+
using and exploiting Genetically Modified Organisms (GMOs) to pursue our vision of an artificial endosymbiotic platform for synthetic biology. The question and debates GMOs raise
 +
all around the globe and in Europe, we have chosen to consider prior to starting our project, but when discussing our ideas and our goals, one has to look past exploration of GMOs.  
 +
  <br>
 +
This does not however mean that the topic should be taken lightly, but simply that this is not our focus, since we as a team have chosen to believe that we are working ethically
 +
sound when working in compliance with guidelines and rules on the topic of GMO laboratories.
 +
<br><br>
 +
Within these laboratories, the GMOs should be contained and thus minimizing the risk of lab generated GMOs in nature. Similarly, future GMOs generated with the “Incell artificial
 +
endosymbiotic platform” would initially be contained within labs - but what if a leak occurs?
 
<br>
 
<br>
 
+
What if an endosymbiotic relationship were to be used in plants to fixate nitrogen in a field setting?
<p>We have identified three mechanisms we believe to be mandatory for the development of a stable endosymbiotic relationship, which we will be trying to replicate in free-living cells. First of all, in order for the relationship to be stable, the two organisms must  be mutually dependent on each other; there must be a mutually beneficial interaction between host and symbiont. Secondly, there has to be some sort of control and synchronization of symbiont replication. If the symbiont were to be replicating freely we could end up with way too many or not enough symbionts in the host.  Finally, a common feature of the endosymbiotic organelles we have looked at, is the transfer of genes from the symbiont to the host. Because of this transfer, the gene and protein expression is taking place in the nucleus and the proteins and metabolites are transported to the organelle. This import of proteins is interesting not just for understanding endosymbiosis, but also for the potential applications in synthetic biology.</p>
+
 
+
 
<br>
 
<br>
 
+
Would the endosymbiont be able to spread from the host and invade other species?
<p>Based on these considerations, we decided to work on three distinct, but intertwined, projects pertaining to endosymbiosis, namely Interdependence, Number Control, and Protein import. We believe that by combining these three projects, a key step towards the understanding of endosymbiosis and its employment in synthetic biology will be obtained. </p>
+
                </div>
+
                <div class="col-lg-5 col-lg-offset-2 col-sm-6">
+
                    <img class="img-responsive" src="img/national-logo.jpg" alt="">
+
                </div>
+
            </div>
+
 
+
        </div>
+
        <!-- /.container -->
+
 
+
    </div>
+
</div>
+
       
+
    <div class="content-section-b">
+
        <div class="container">
+
            <div class="row">
+
                <div class="col-lg-5 col-lg-offset-1 col-sm-push-6  col-sm-6">
+
                    <hr class="section-heading-spacer">
+
                    <div class="clearfix"></div>
+
                    <h2 class="section-heading">Applications and Implications</h2>
+
                    <p>By understanding the basic principles behind the creation of stable endosymbiotic events we hope that in the future it will be possible to use artificial endosymbiosis as a new technology in synthetic biology, and we believe that value can be created in the foundational track of the iGEM competition. History has shown that great scientific advances has followed the implementation of new revolutionary technologies (Gershon 2003). </p>
+
 
<br>
 
<br>
<p>We envision that artificial endosymbiosis could be applied in a broad range of fields, including agriculture, medicine and production of valuable compounds. A deeper understanding of the relationships intertwining endosymbionts and their hosts could unravel new knowledge applicable for the treatment of mitochondrial diseases, while a living compartment able to fixate nitrogen from the air could decrease the fertilizer use in agricultural production. </p>
+
Would it be able to live in nature? Would it encroach on other biological niches?
 
<br>
 
<br>
<p>However, the applications are only limited by the imagination of future users. Indeed, the game-changing role of endosymbiosis has not gone unseen to the eyes of the modern bioengineers, who predict that the establishment of a novel interaction has the potential to radically alter the host cell physiology without directly affecting the host genome (Scientific America Vol 105 pp. 36-45).</p>
+
Which of the biological realms of life would such a host-endosymbiont GMO be a part of?
 +
<br><br>
 +
In the late days of September, we hosted an event where professionals and layman alike could join in on a <a href="2017.igem.org/Team:UCopenhagen/Events">lecture session</a> followed
 +
by a panel discussion relating to the science and ethics of synthetic biology. Here more than a 100 people joined us and from this debate, we as a team gained insights into different worldviews, new perspectives on synthetic
 +
biology and some curious question, similar to the ones above.
 +
<br><br>
 +
From this debate, it became clear that one of the largest concerns were the possibilities of ecological disaster if a “break-out” of GMOs were to occur. In this initial stage
 +
of the Incell project, before the first endosymbiont has even been designed, we closely follow all lab instructions and rules for working with GMOs, thus lowering the risk for a
 +
breakout significantly. However, one of our future prospects would as mentioned previously be to use a plant host cell with a nitrogen-fixating bacterium to form a host-endosymbiont
 +
system capable of fixating nitrogen. This late stage system should be no-risk or the lowest possible risk for potential break-outs and/or endosymbiont escape from the host.
 
<br>
 
<br>
<p>Before the potential application of artificial endosymbiosis, there are many things to consider. While the current regulations regarding GMO limits what is possible to apply in agriculture and medicine, regulations regarding synthetically modified organisms (SMOs) have not yet been systematically put into place. How will a new field of SMO be regulated, and how will it influence possible applications of artificial endosymbiosis?</p>
+
Another question is the possibility of the endosymbiont to become invasive. If it can live inside a eukaryotic cell, could it then invade other cells? Other
 +
experiments on Endosymbiosis are using Invasin proteins, to allow for endosymbionts to “penetrate” a host cell, this however is not the vision of Incell. Systems relying on
 +
Invasin require the endosymbionts to live, for brief periods, outside a host and to invade another one. For this particular reason, we chose to work on a system without Invasin,
 +
to minimize the risk of having endosymbionts invading other host cells and potentially becoming parasitic. Instead, we would suggest the usage of either a syringe or a poration
 +
method to seed the host with endosymbionts. This should eliminate the possibility of invasive and parasitic endosymbionts.
 +
<br><br>
 +
Lastly but not least, are we playing gods or toying with nature that no man (or woman) was ever meant to alter? The question many scientists in synthetic biology have faced.  
 +
A question that can split the field and the public opinion on GMOs and synthetic biology. But why do we Incell mention this question? Well if we or someone else manages to
 +
setup an artificial endosymbiotic platform, we would alter and maybe fuse evolutionary paths. In the sense that an eukaryotic organism, such as baker’s yeast, would join
 +
forces with a prokaryote, such as E. coli, combining to realms of life and fusing to evolutionary strains into something else. Similar to other fields of synthetic biology
 +
this host-endosymbionts would be outside our current classification of life. However, this does not mean that we are creating life, simply that we explore the possibility of
 +
a deep and profound collaboration between species to harness some of the wonders of biology. We aim at harnessing the endosymbiotic relation to give a new tool to synthetic biology.
 
<br>
 
<br>
<p>In addition to our scientific investigation we are enthused to trigger debate about synthetic biology. We intend to podcast intriguing conversations with experts, thereby hoping to reach the general public and impel the discussion about the ethics and future prospects in combining biology and engineering.</p>
+
A tool we believe requires careful, but thorough exploration and honest consideration. So we can understand the risk mentioned above and if these can be resolved potentially
                     
+
use such a technology to solve some of the task we face today.
                    </div>
+
<br><br>
                    <div class="col-lg-6 col-sm-pull-6  col-sm-6">
+
Are we playing gods? No, we are simply exploring the marvels of biology.
                   
+
 
                        <img class="img-responsive2" src="img/Lacrosse2.jpg" alt="">
+
</p>
                    </div>
+
 
                </div>
+
</div>
                </div>
+
  </div>
            </div>
+
 
</div>
 
</div>
 
 
<a  name="socialmeida"></a>
 
    <div class="banner">
 
  
 +
   
 +
<a  name="socialmedia"></a>
 
         <div class="container">
 
         <div class="container">
 
+
          <div class="row">
            <div class="row">
+
                 <div class="col-lg-5">
                 <div class="col-lg-6">
+
                     <h2>Find Incell here:</h2>
                     <h2>Find inCell here:</h2>
+
 
                 </div>
 
                 </div>
                 <div class="col-lg-6">
+
                 <div class="col-lg-7">
 +
<br>
 
                     <ul class="list-inline banner-social-buttons">
 
                     <ul class="list-inline banner-social-buttons">
 
                         <li>
 
                         <li>
Line 111: Line 101:
 
                 </div>
 
                 </div>
 
             </div>
 
             </div>
 
+
</div>
 
         </div>
 
         </div>
 
         <!-- /.container -->
 
         <!-- /.container -->
 +
    </div>
 +
    <!-- /.intro-header -->
  
 
     </div>
 
     </div>
Line 140: Line 132:
 
                     </li>
 
                     </li>
 
                     <li>
 
                     <li>
                         <a class="page-scroll" href="https://2017.igem.org/Team:UCopenhagen/HP/Events">Next</a>
+
                         <a class="page-scroll" href= "https://2017.igem.org/Team:UCopenhagen/HP/Gold_Integrated">Next</a>
 
                     </li>
 
                     </li>
 
                 </ul>
 
                 </ul>

Latest revision as of 03:54, 2 November 2017

E T H I C S

Similar to most iGEM projects Incell as a scientific project heavily relies on our’s and the scientific community’s ability to genetically modify organisms. In other words, we are using and exploiting Genetically Modified Organisms (GMOs) to pursue our vision of an artificial endosymbiotic platform for synthetic biology. The question and debates GMOs raise all around the globe and in Europe, we have chosen to consider prior to starting our project, but when discussing our ideas and our goals, one has to look past exploration of GMOs.
This does not however mean that the topic should be taken lightly, but simply that this is not our focus, since we as a team have chosen to believe that we are working ethically sound when working in compliance with guidelines and rules on the topic of GMO laboratories.

Within these laboratories, the GMOs should be contained and thus minimizing the risk of lab generated GMOs in nature. Similarly, future GMOs generated with the “Incell artificial endosymbiotic platform” would initially be contained within labs - but what if a leak occurs?
What if an endosymbiotic relationship were to be used in plants to fixate nitrogen in a field setting?
Would the endosymbiont be able to spread from the host and invade other species?
Would it be able to live in nature? Would it encroach on other biological niches?
Which of the biological realms of life would such a host-endosymbiont GMO be a part of?

In the late days of September, we hosted an event where professionals and layman alike could join in on a lecture session followed by a panel discussion relating to the science and ethics of synthetic biology. Here more than a 100 people joined us and from this debate, we as a team gained insights into different worldviews, new perspectives on synthetic biology and some curious question, similar to the ones above.

From this debate, it became clear that one of the largest concerns were the possibilities of ecological disaster if a “break-out” of GMOs were to occur. In this initial stage of the Incell project, before the first endosymbiont has even been designed, we closely follow all lab instructions and rules for working with GMOs, thus lowering the risk for a breakout significantly. However, one of our future prospects would as mentioned previously be to use a plant host cell with a nitrogen-fixating bacterium to form a host-endosymbiont system capable of fixating nitrogen. This late stage system should be no-risk or the lowest possible risk for potential break-outs and/or endosymbiont escape from the host.
Another question is the possibility of the endosymbiont to become invasive. If it can live inside a eukaryotic cell, could it then invade other cells? Other experiments on Endosymbiosis are using Invasin proteins, to allow for endosymbionts to “penetrate” a host cell, this however is not the vision of Incell. Systems relying on Invasin require the endosymbionts to live, for brief periods, outside a host and to invade another one. For this particular reason, we chose to work on a system without Invasin, to minimize the risk of having endosymbionts invading other host cells and potentially becoming parasitic. Instead, we would suggest the usage of either a syringe or a poration method to seed the host with endosymbionts. This should eliminate the possibility of invasive and parasitic endosymbionts.

Lastly but not least, are we playing gods or toying with nature that no man (or woman) was ever meant to alter? The question many scientists in synthetic biology have faced. A question that can split the field and the public opinion on GMOs and synthetic biology. But why do we Incell mention this question? Well if we or someone else manages to setup an artificial endosymbiotic platform, we would alter and maybe fuse evolutionary paths. In the sense that an eukaryotic organism, such as baker’s yeast, would join forces with a prokaryote, such as E. coli, combining to realms of life and fusing to evolutionary strains into something else. Similar to other fields of synthetic biology this host-endosymbionts would be outside our current classification of life. However, this does not mean that we are creating life, simply that we explore the possibility of a deep and profound collaboration between species to harness some of the wonders of biology. We aim at harnessing the endosymbiotic relation to give a new tool to synthetic biology.
A tool we believe requires careful, but thorough exploration and honest consideration. So we can understand the risk mentioned above and if these can be resolved potentially use such a technology to solve some of the task we face today.

Are we playing gods? No, we are simply exploring the marvels of biology.

Find Incell here: